Oral paclitaxel matched IV in progression-free survival but outperformed it in overall survival for second-line advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback